Is HET/SAFB a Tumor Suppressor Gene in Breast Cancer? Generation of a Mouse Model

Abstract

The scaffold attachment factor HET/SAFB 1 maps to a chromosomal locus that displays extremely high loss of heterozygozity (78%) in estrogen depend of the breast cancers. My mentors lab has shown that HET/SAFB I functions as a co-repressor of estrogen receptor transcriptional activation. We hypothesize that HET/SAFB 1 is a tumor suppressor gene. To test this hypothesis we created a mouse knockout model. During the first year of my grant we established 2 independent lines of HET/SAFBl knockout mice. During the second year of my grant we found that loss of HET/SAFBl function resulted in multiple phenotypes including prenatal and postnatal lethality, growth retardation, male infertility, female sub-fertility and hyperplasia of the mammary gland. During the third year we found that low levels of Estradiol and IGF-1 repress early development of mammary gland in knockout females. The hormone stimulation (E2) increased branching and lobulo-alveolar development, increased proliferation (BrdU) and co-localization of ER+ and proliferation. These studies show that HET/SAFB-l is involved in the hormonal regulation of development and maturation of the reproductive system and the mammary gland. Tumorogenesis studies are ongoing.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2004
Accession Number
ADA428255

Entities

People

  • Margarita Ivanova
  • Steffi Oesterreich

Organizations

  • Baylor College of Medicine

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Antigens
  • Blood
  • Body Weight
  • Breast Cancer
  • Cells
  • Demographic Cohorts
  • Embryos
  • Epithelial Cells
  • Genitalia
  • Germ Cells
  • Mammary Glands
  • Reproductive System
  • Sex Glands
  • Statistical Analysis
  • Stem Cells
  • Testes
  • Urogenital System

Fields of Study

  • Biology

Readers

  • Molecular Biology and Genetics
  • Molecular and genetic basis of cancer.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.